Rockefeller Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-197
| Closed | -$98K | – | 3848 |
|
|
2021
Q3 | $98K | Hold |
197
| – | – | ﹤0.01% | 1868 |
|
|
2021
Q2 | $107K | Sell |
197
-5
| -2% | -$2.72K | ﹤0.01% | 1777 |
|
|
2021
Q1 | $125K | Hold |
202
| – | – | ﹤0.01% | 1513 |
|
|
2020
Q4 | $113K | Buy |
202
+3
| +2% | +$1.68K | ﹤0.01% | 1391 |
|
|
2020
Q3 | $126K | Buy |
199
+2
| +1% | +$1.27K | ﹤0.01% | 1180 |
|
|
2020
Q2 | $169K | Hold |
197
| – | – | ﹤0.01% | 1002 |
|
|
2020
Q1 | $123K | Hold |
197
| – | – | ﹤0.01% | 960 |
|
|
2019
Q4 | $205K | Hold |
197
| – | – | ﹤0.01% | 761 |
|
|
2019
Q3 | $169K | Hold |
197
| – | – | ﹤0.01% | 665 |
|
|
2019
Q2 | $260K | Hold |
197
| – | – | ﹤0.01% | 537 |
|
|
2019
Q1 | $289K | Hold |
197
| – | – | ﹤0.01% | 549 |
|
|
2018
Q4 | $242K | Buy |
+197
| New | +$242K | ﹤0.01% | 387 |
|